|2.||End Stage Liver Disease
|5.||Pathologic Constriction (Stenosis)
|1.||Fan, Daiming: 6 articles (01/2015 - 03/2013)|
|2.||Qi, Xingshun: 6 articles (01/2015 - 03/2013)|
|3.||Plessier, Aurélie: 6 articles (01/2012 - 04/2005)|
|4.||Burroughs, Andrew K: 6 articles (01/2009 - 06/2003)|
|5.||Krawczyk, Marek: 5 articles (01/2014 - 09/2003)|
|6.||Shibata, Toshiya: 5 articles (11/2013 - 04/2002)|
|7.||Patch, David: 5 articles (01/2009 - 06/2003)|
|8.||Zu, Maoheng: 4 articles (11/2015 - 01/2014)|
|9.||Bahr, Matthias J: 4 articles (10/2015 - 12/2003)|
|10.||Manns, Michael P: 4 articles (08/2015 - 12/2003)|
01/01/2007 - "A patient with the acute Budd-Chiari syndrome was administered myelosuppressants and anticoagulants on time so reperfusion was restored. "
01/01/2005 - "Putting all data together it could be speculated that weight reduction (along with anticoagulants) considerably activated endogenous fibrinolysis, resulting in spontaneous resolution of Budd-Chiari syndrome. "
01/01/2009 - "Hepatic function was stabilized in parallel to controlling ulcerative colitis and the patient is in good health until now receiving maintenance therapy for ulcerative colitis and anticoagulants for Budd-Chiari syndrome."
02/01/2012 - "In this review, we present some different and special conditions that are generally being treated with anticoagulants such as cerebral vein thrombosis (CVT), mesenteric vein thrombosis (MVT), Budd-Chiari syndrome (BCS), and Pulmonary Hypertension (PH) despite the lack of controlled clinical trials. "
07/01/1994 - "In conclusion patients with Budd-Chiari syndrome should be tested for lupus anticoagulants and anticardiolipin antibodies, Budd-Chiari syndrome resulting from this cause may have a good response to treatment with oral anticoagulants; this treatment should be maintained permanently, and pregnancy in such patients may initiate serious difficulties."
|2.||Polytetrafluoroethylene (Teflon)FDA Link
11/01/2004 - "PTFE-covered stents are preferable in patients with Budd-Chiari Syndrome."
11/01/2004 - "PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome."
09/01/1997 - "This report describes a patient with Budd-Chiari syndrome who was operated on successfully by means of shunt formation with polytetrafluoroethylene graft between the inferior vena cava (IVC) and right atrium. "
09/01/1997 - "Retrohepatic cavoatrial shunt with a ringed polytetrafluoroethylene graft for the Budd-Chiari syndrome. "
05/01/1989 - "Five patients with the Budd-Chiari syndrome and caval occlusion and/or obstruction have had mesoatrial shunts constructed using externally supported polytetrafluoroethylene grafts. "
|3.||Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
11/01/1983 - "Urokinase treatment of Budd-Chiari syndrome."
09/01/1994 - "The hepatic venous outflow obstruction was relieved by angioplasty and thrombolytic therapy with use of local infusions of urokinase into the clot. "
02/01/2011 - "This study was undertaken to evaluate the safety and feasibility of thrombolytic urokinase treatment after predilation in patients with Budd-Chiari syndrome (BCS) with chronic inferior vena cava (IVC) thrombosis. "
02/01/2011 - "Treatment of Budd-Chiari syndrome with urokinase following predilation in patients with old inferior vena cava thrombosis."
07/01/1964 - "VI. THE EFFECTS OF HEPATIC VENOUS OUTFLOW OBSTRUCTION AND ASCITES ON ALDOSTERONE SECRETION."
06/01/1997 - "In the experimental studies, side-to-side portacaval shunt permanently relieved severe ascites, reduced the 13-fold increase in thoracic duct lymph flow rate to almost normal, and abolished the aldosterone hypersecretory response to minimal hepatic venous outflow obstruction. "
06/01/1997 - "In the experimental studies, hepatic venous outflow obstruction and massive ascites were produced in dogs by ligation of the hepatic veins, and the effect of portacaval shunts on ascites, thoracic duct lymph flow, and aldosterone secretion were measured. "
|5.||Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
08/01/2003 - "The case of a 42-year-old female with Budd-Chiari syndrome (BCS) and lupus anticoagulant is reported. "
04/01/1991 - "Association of the Budd-Chiari syndrome with lupus anticoagulant. "
01/01/1986 - "An active search for the 'lupus' anticoagulant should be performed to lower the percentage of apparently idiopathic cases of Budd-Chiari syndrome."
01/01/1986 - "Three patients with Budd-Chiari syndrome in association with the 'lupus' anticoagulant are described. "
08/01/1985 - "[A case of Budd-Chiari syndrome with lupus anticoagulant]."
|6.||Heparin (Liquaemin)FDA LinkGeneric
01/01/1997 - "Therapeutic options of Budd-Chiari syndrome include anticoagulation with heparin, fibrinolysis followed by oral anticoagulation, and appropriate treatment of the underlying PMD. "
04/01/2001 - "Budd--Chiari syndrome and heparin-induced thrombocytopenia."
01/01/2001 - "[Challenging perioperative anticoagulation in a patient with Budd-Chiari syndrome and heparin-induced thrombocytopenia]."
01/01/2000 - "This case shows that heparin-induced thrombocytopenia II is a possible cause of the Budd-Chiari syndrome."
01/01/2000 - "Segmental hepatic vein thrombosis associated with heparin-induced thrombocytopenia II."
|7.||Warfarin (Coumadin)FDA LinkGeneric
10/27/2002 - "Patients who undergo orthotopic liver transplantation (OLT) for Budd-Chiari syndrome (BCS) traditionally have been anticoagulated with warfarin postoperatively. "
04/01/2011 - "To evaluate the initial clinical safety and feasibility of anticoagulation using warfarin for Budd-Chiari syndrome (BCS) with chronic inferior vena cava (IVC) thrombosis. "
04/01/2011 - "Anticoagulation with warfarin for Budd-Chiari syndrome with chronic inferior vena cava thrombosis: an initial clinical experience."
11/01/2014 - "To evaluate the safety and clinical efficacy of warfarin anticoagulation after balloon dilation alone for the treatment of Budd-Chiari syndrome (BCS) complicated by old inferior vena cava (IVC) thrombosis. "
11/01/2014 - "Clinical outcomes of warfarin anticoagulation after balloon dilation alone for the treatment of Budd-Chiari syndrome complicated by old inferior vena cava thrombosis."
12/01/2013 - "Budd-Chiari syndrome in very young adult patients with polycythemia vera: report of case series with good outcome with direct thrombin inhibitor treatment."
06/01/2010 - "We report a four year old boy who presented with liver failure secondary to anti-thrombin III deficiency related Budd Chiari syndrome. "
08/01/2014 - "We measured thrombin generation in the presence and absence of thrombomodulin in patients with portal vein thrombosis (PVT, n=47), Budd-Chiari syndrome (BCS, n=15) and cirrhosis (n=24) and compared the results to those obtained from healthy controls (n=21). "
01/01/2008 - "Budd-Chiari syndrome in a young female with factor V Leiden mutation: successful treatment with lepirudin, a direct thrombin inhibitor."
03/01/2003 - "Biochemical liver function tests, and measurement of prothrombin time, activated partial thromboplastin time, and plasma levels of anti-thrombin III (antigen) and activity of protein C were done in 36 patients with Budd-Chiari syndrome. "
01/01/1998 - "Anticardiolipin antibody-related Budd-Chiari syndrome: report of a case."
07/01/1994 - "Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatment."
03/01/2000 - "This is the first reported case of a young patient with ulcerative colitis who developed acute Budd-Chiari syndrome and was found positive for anticardiolipin antibodies. "
03/01/2000 - "Budd-Chiari syndrome in a patient with ulcerative colitis: association with anticardiolipin antibodies."
06/01/1998 - "Significance of elevated IgG anticardiolipin antibody levels in patients with Budd-Chiari syndrome."
|10.||Cyclosporine (Ciclosporin)FDA LinkGeneric
01/01/2003 - "Case 2 was a female patient with advanced acute lymphoblastic leukaemia (ALL) with post bone marrow transplantation (BMT) acute haemolytic-uraemic syndrome (HUS) secondary to cyclosporin A (Cy A), cytomegalovirus (CMV) infection, severe nosocomial pneumonia, acute renal failure (ARF) treated with continuous haemofiltration and acute veno-occlusive disease resulting in Budd-Chiari syndrome. "
04/01/2004 - "Early treatment with heparin and cyclosporin administered intravenously induce a remission of intestinal disease and total disappearance of hepatic vein thrombosis. "
10/01/2008 - "Early posttransplant hepatic venous outflow obstruction: Long-term efficacy of primary stent placement."
02/01/2003 - "Budd-Chiari syndrome due to prothrombotic disorder: mid-term patency and efficacy of endovascular stents."
01/01/1999 - "The object of this study was to evaluate use of ultrasound (US) as guidance for IVC stent placement for the management of Budd-Chiari syndrome. "
09/01/1997 - "[Clinical study of expandable venous stents for treatment of Budd-Chiari syndrome]."
05/01/1991 - "This study presents a patient with clinical resolution of the Budd-Chiari syndrome after placement of expandable metallic stents in the inferior vena cava and hepatic veins. "
09/01/2015 - "In conclusion, endovascular intervention is very effective in hepatic venous outflow obstruction following pediatric liver transplantation. "
12/01/2010 - "Liver transplantation in Budd-Chiari syndrome remains controversial; however, some improved techniques lead to better results. "
01/01/2012 - "The purpose of this study was to assess the value and results of liver transplantation in the treatment of Budd-Chiari syndrome. "
08/01/2010 - "The aim of this study was to evaluate retrospectively the outcome of percutaneous transluminal venoplasty (PTV) after venous pressure measurement in patients with hepatic venous outflow obstruction following living donor liver transplantation (LDLT). "
07/01/2009 - "The objective of this study was to describe by a retrospective analysis the evolution of patients who needed an end-to side cavo-cavostomy in addition to a previous cavo-caval anastomosis, during orthotopic liver transplantation (OLT), caused by hepatic venous outflow obstruction. "
07/15/2008 - "To evaluate the therapeutic efficacy of interposition of graft meso-cavo-atri shunt (MCAS) for the treatment of Budd-Chiari syndrome (BCS) with occlusion of both inferior cava vena (ICV) and hepatic veins (HVs). "
08/01/2010 - "In this study, we present the unique findings of multidetector computed tomography (MDCT) angiography for a liver transplant candidate with Budd-Chiari syndrome caused by a web in the proximal IVC. "
12/01/2015 - "After completing the vascular anastomosis, a severe hepatic venous outflow obstruction from the graft developed due to compression of the inferior vena cava from the hypertrophied right posterior lobe of the graft. "
10/01/2015 - "Response to Time to resize the role of liver transplant for Budd-Chiari syndrome."
10/01/2015 - "Time to resize the role of liver transplant for Budd-Chiari syndrome."
|4.||Surgical Portasystemic Shunt (Portosystemic Shunt)
09/01/2007 - "In patients with acute or subacute Budd-Chiari syndrome uncontrolled by medical therapy, transjugular intrahepatic portosystemic shunt is highly effective with no complications and an associated mid-term clinical success."
08/01/2008 - "This study was performed to evaluate the safety and efficacy of transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of patients affected by Budd-Chiari syndrome (BCS). "
03/01/2010 - "The aim of this study was to determine the outcome of a modified transjugular intrahepatic portosystemic shunt (MTIPS) in the treatment of the Budd-Chiari syndrome (BCS, occlusion of the hepatic veins). "
09/01/2007 - "The aim of our study was to present two patients with Budd-Chiari syndrome treated with transjugular intrahepatic portosystemic shunt. "
07/01/1999 - "The aim of this study was to assess the factors, including surgical portosystemic shunts, which affect survival in adults with Budd-Chiari syndrome. "
|5.||Angioplasty (Angioplasty, Transluminal)
04/01/1987 - "It is concluded that percutaneous transluminal angioplasty is a safe and effective mode of therapy in the management of the Budd-Chiari syndrome due to membranous obstruction of the hepatic portion of the inferior vena cava or the hepatic veins."
01/01/2011 - "Several therapeutic modalities, including percutaneous transluminal angioplasty, have been attempted to save the life of patients with Budd-Chiari syndrome. "
08/01/2009 - "[A case of Budd-Chiari syndrome type IV, successfully treated with percutaneous transluminal angioplasty (PTA)]."
01/01/2008 - "Doppler waveform pattern changes in a patient with primary Budd-Chiari syndrome before and after angioplasty."
11/01/2004 - "[Budd-Chiari syndrome with complete occlusion of the inferior vena cava: percutaneous recanalization by angioplasty and stenting]."